Infliximab for Treatment of Adults Hospitalized with Moderate or Severe Covid-19.
O'Halloran J, Kedar E, Anstrom KJ, McCarthy MW, Ko ER, Segura Nunez P, Boucher C, Smith PB, Panettieri RA, Mendivil Tuchia de Tai S, Maillo M, Khan A, Mena Lora AJ, Salathe M, Capo G, Rodriguez Gonzalez D, Patterson TF, Palma C, Ariza H, Patelli Lima M, Lachiewicz AM, Blamoun J, Nannini E, Sprinz E, Mykietiuk A, Alicic R, Rauseo AM, Wolfe CR, Wittig B, Benjamin DK, McNulty SE, Zakroysky P, Halabi S, Butler S, Atkinson J, Adam SJ, Melsheimer R, Chang S, LaVange L, Proschan M, Bozzette SA, Powderly WG.
O'Halloran J, et al. Among authors: rauseo am.
medRxiv. 2022 Sep 26:2022.09.22.22280245. doi: 10.1101/2022.09.22.22280245. Preprint.
medRxiv. 2022.
PMID: 36172138
Free PMC article.